ChemComm
Communication
Table 3 Scope investigation of the reaction of 2-(2-alkynyl)benzenesulfonamide 1
with trifluoromethanesulfanylamide 2a
3 Bioorganic and Medicinal Chemistry of Fluorine, ed. J.-P. Begue and
D. Bonnet-Delpon, Wiley, Hoboken, 2008.
4 For selected examples, see: (a) C. Chen, L. Chu and F.-L. Qing,
J. Am. Chem. Soc., 2012, 134, 12454; (b) F. Baert, J. Colomb and
T. Billard, Angew. Chem., Int. Ed., 2012, 51, 10382; (c) G. Teverovskiy,
D. S. Surry and S. L. Buchwald, Angew. Chem., Int. Ed., 2011,
50, 7312; (d) C.-P. Zhang and D. A. Vicic, J. Am. Chem. Soc., 2012,
134, 183; (e) Z. Weng, W. He, C. Chen, R. Lee, D. Tan, Z. Lai,
D. Kong, Y. Yuan and K.-W. Huang, Angew. Chem., Int. Ed., 2013,
52, 1548; ( f ) C. Chen, Y. Xie, L. Chu, R.-W. Wang, X. Zhang and
F.-L. Qing, Angew. Chem., Int. Ed., 2012, 51, 2492; (g) C.-P. Zhang and
D. A. Vicic, Chem.–Asian J., 2012, 7, 1756; (h) X. Shao, X. Wang,
T. Yang, L. Lu and Q. Shen, Angew. Chem., Int. Ed., 2013, 52, 3457;
(i) L. D. Tran, I. Popov and O. Daugulis, J. Am. Chem. Soc., 2012,
134, 18240.
Yield (%)
Entry
R1
R2
3
4
1
2
3
4
5
6
7
8
Me
H
Cl
CF3
H
H
H
Cyclopropyl
Cyclopropyl
Cyclopropyl
Cyclopropyl
nBu
CH2CH2OCOEt
CH2CH2CH2Cl
CH2CH2CH2CN
23 (3n)
43 (3o)
52 (3p)
42 (3q)
38 (3r)
30 (3s)
45 (3t)
18 (3u)
61 (4a)
37 (4b)
0
0
5 (a) A. Tlili and T. Billard, Angew. Chem., Int. Ed., 2013, 52, 6818;
(b) Y. Yang, X. Jiang and F.-L. Qing, J. Org. Chem., 2012, 77, 7538;
46 (4c)
40 (4d)
29 (4e)
45 (4f)
´
(c) A. Ferry, T. Billard, E. Bacque and B. R. Langlois, J. Fluorine
Chem., 2012, 134, 160; (d) A. Ferry, T. Billard, B. R. Langlois and
H
´
E. Bacque, J. Org. Chem., 2008, 73, 9362.
a
6 (a) C. Valent, R. C. Guedes, R. Moreia, J. Iley, J. Gut and P. J.
Rosenthal, Bioorg. Med. Chem. Lett., 2006, 16, 4115; (b) L. Zhuang,
J. S. Wai, M. W. Embrey, T. E. Fisher, M. S. Egbertson, L. S. Payne,
J. P. Guare, J. P. Vacca, D. J. Hazuda, P. J. Felock, A. L. Wolfe, K. A.
Stilmock, M. V. Witmer, G. Moyer, W. A. Schleif, L. J. Gabryelski,
Y. M. Leonard, J. J. Lynch, S. R. Michelson and S. D. Young,
J. Med. Chem., 2003, 46, 453; (c) Y. Misu and H. Togo, Org. Biomol.
Chem., 2003, 11, 1342; (d) K. H. Ahn, S. K. Kim and C. Ham,
Tetrahedron Lett., 1998, 39, 6321.
Isolated yield based on 2-(2-alkynyl)benzenesulfonamide 1.
attached to the aromatic ring of 2-(2-alkynyl)benzenesulfonamide 1
(Table 3, entries 3 and 4).
In conclusion, we have reported an efficient synthesis of
4-((trifluoromethyl)thio)-2H-benzo[e][1,2]thiazine 1,1-dioxides
through a reaction of 2-(2-alkynyl)benzenesulfonamide with
trifluoromethanesulfanylamide. 2,3-Dihydrobenzo[d]isothiazole
1,1-dioxide could be formed as well in some cases. The presence
of BiCl3 was essential for a successful transformation. The
introduction of (trifluoromethyl)thio moiety (SCF3) into other
N-heterocycles is currently under exploration in our laboratory.
Financial support from the National Natural Science Founda-
tion of China (No. 21032007, 21172038) is gratefully acknowledged.
7 G. J. Wells, M. Tao, K. A. Josef and R. Bihovsky, J. Med. Chem., 2001,
44, 3488.
8 C. Hansch, A. Leo and R. W. Taft, Chem. Rev., 1991, 91, 165.
9 (a) R. E. Banks, B. E. Smart and J. C. Tatlow, Organofluorine
Chemistry: Principles and Commercial Applications, Plenum, New
York, 1994; (b) T. Hiyama, Organofluorine Compounds: Chemistry
and Properties, Springer, Berlin, 2000, ch. 5, pp. 137–182;
(c) B. R. Langlois, T. Billard, S. Large and N. Roques, Fluorinated
Bioactive Compounds, Fluorine Technology Ltd, Cheshire, 1999,
Paper 24; (d) J. Szmuszkovicz, J. Med. Chem., 1966, 9, 527; (e) S. C.
Cherkofsky, US Pat. US 4267184, 1981, (Chem. Abstr., 1981, 95,
61982).
10 (a) D. P. Walsh and Y.-T. Chang, Chem. Rev., 2006, 106, 2476;
(b) P. Arya, D. T. H. Chou and M.-G. Baek, Angew. Chem., Int. Ed.,
2001, 40, 339; (c) S. L. Schreiber, Science, 2000, 287, 1964;
(d) M. D. Burke and S. L. Schreiber, Angew. Chem., Int. Ed.,
2004, 43, 46; (e) S. L. Schreiber, Nature, 2009, 457, 153;
( f ) D. S. Tan, Nat. Chem. Biol., 2005, 1, 74; (g) C. Cordier,
D. Morton, S. Murrison, A. Nelson and C. O’Leary-Steele, Nat. Prod.
Rep., 2008, 25, 719.
Notes and references
1 (a) R. Filler and Y. Kobayashi, Biomedicinal Aspects of Fluorine Chemistry,
Elsevier, Amsterdam, 1982; (b) in Fluorine in Bioorganic Chemistry,
ed. J. T. Welch and S. Eswarakrishman, Wiley, New York, 1991.
2 For some reviews on the synthesis of fluorinated heterocycles,
see: (a) V. A. Petrov, Fluorinated Heterocyclic Compounds: Synthesis,
Chemistry, and Applications, John Wiley & Sons, Inc., Hoboken, NJ,
2009; (b) E. V. Nosova, G. N. Lipunova, V. N. Charushin and
O. N. Chupakhin, J. Fluorine Chem., 2010, 131, 1267; (c) S. Zhu, 11 For selected examples, see: (a) A. Ferry, T. Billard, B. R. Langlois and
´
E. Bacque, Angew. Chem., Int. Ed., 2009, 48, 8551; (b) A. Ferry,
Y. Wang, W. Peng, L. Song and G. Jin, Curr. Org. Chem., 2002,
6, 1057; (d) M. J. Silvester, Aldrichimica Acta, 1991, 24, 31For some
selective examples, see: (e) P. Kwiatkowski, T. D. Beeson, J. C.
´
T. Billard, B. R. Langlois and E. Bacque, J. Org. Chem., 2008,
73, 9362.
´
Conrad and D. W. C. MacMillan, J. Am. Chem. Soc., 2011, 133, 12 (a) A. Ferry, T. Billard, B. R. Langlois and E. Bacque, J. Org. Chem.,
´
1738; ( f ) Y. Kishi, H. Nagura, S. Inagi and T. Fuchigami, Chem.
Commun., 2008, 3876; (g) S. Fustero, S. Catalan, M. Sanchez-Rosello,
A. Simon-Fuentes and C. del Pozo, Org. Lett., 2010, 12, 3484; (h) T. Xu
and G. Liu, Org. Lett., 2012, 14, 5416; (i) S. Ye, J. Liu and J. Wu,
Chem. Commun., 2012, 48, 5028.
2008, 73, 9362; (b) A. Ferry, T. Billard, B. R. Langlois and E. Bacque,
Angew. Chem., Int. Ed., 2009, 48, 8551; (c) A. Ferry, T. Billard,
E. Bacque and B. R. Langlois, J. Fluorine Chem., 2012, 134, 160;
(d) Y. Yang, X. Jiang and F.-L. Qing, J. Org. Chem., 2012, 77, 7538;
(e) J. Liu, L. Chu and F.-L. Qing, Org. Lett., 2013, 15, 894.
´
c
This journal is The Royal Society of Chemistry 2013
Chem. Commun., 2013, 49, 8647--8649 8649